Cargando…
Development of Point-of-Care Biosensors for COVID-19
Coronavirus disease 2019 (COVID-19) outbreak has become a global pandemic. The deleterious effects of coronavirus have prompted the development of diagnostic tools to manage the spread of disease. While conventional technologies such as quantitative real time polymerase chain reaction (qRT-PCR) have...
Autor principal: | Choi, Jane Ru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267686/ https://www.ncbi.nlm.nih.gov/pubmed/32574316 http://dx.doi.org/10.3389/fchem.2020.00517 |
Ejemplares similares
-
Emerging point-of-care biosensors for rapid diagnosis of COVID-19: current progress, challenges, and future prospects
por: Rasmi, Yousef, et al.
Publicado: (2021) -
Recent Trends in Nanomaterial-Based Biosensors for Point-of-Care Testing
por: Wang, Xu, et al.
Publicado: (2020) -
Clinically oriented Alzheimer's biosensors: expanding the horizons towards point-of-care diagnostics and beyond
por: Murti, Bayu Tri, et al.
Publicado: (2021) -
Editorial: Advances in Nucleic Acid-Based Biosensors and Imaging
por: Choi, Jane Ru, et al.
Publicado: (2022) -
Progress in Biosensors for the Point-of-Care Diagnosis of COVID-19
por: Pohanka, Miroslav
Publicado: (2022)